PRZOOM - /newswire/ -
Morrisville, NC, United States, 2010/04/12 - Compliance Implementation Services (CIS) announced today that Judy Fox, CIS Director for U.S. Global Compliance, has been elected to the PDMA Alliance, Inc. Board of Directors.
Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Judy Fox, CIS Director for U.S. Global Compliance, has been elected to the PDMA Alliance Inc. Board of Directors.
“The very nature of the PDMA Alliance is to be an organization ‘by the industry for the industry,’ and through the Alliance, I’ve been a resource to the industry members for several years,” said Ms. Fox. “As a result, I’m prepared to bring PDMA and general compliance concerns to the rest of the board.”
In addition to acting as an industry resource, the PDMA Alliance Board is responsible for ensuring that content and speakers are relevant to the attendees of the 20th Annual PDMA Sharing Conference being held October 3-6, 2010 at the Hilton San Diego Bayfront in San Diego, California, USA.
“The annual conference is the industry’s premier sample accountability and compliance conference,” said Fox. “And while we will continue to focus on the most effective compliance solutions for sample accountability professionals, this year the Alliance is enhancing the conference content to include fraud and abuse. Some aspects of the new Fraud and Abuse educational opportunities will feature related topics such as Investigations, PhRMA Code, Anti-kickback, OIG, Sunshine Act, and Risk Assessment. As a compliance consultant, I can address the industry best practices and risks we see in all of these areas.”
In the past ten years, Ms. Fox has amassed diverse experience in the pharmaceutical industry in the areas of compliance, regulatory affairs, commercial operations, quality assurance, and inventory management. In addition, Ms. Fox has lead CIS’s PDMA and State Reporting services offerings.
Compliance Implementation Services (cis-partners.com) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research and Development through U.S. Commercial Compliance and Government Programs. Founded in 2004, the firm’s deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions help its clients establish a “Culture of Compliance” that is both meaningful and practical.
CIS experts quickly identify exposure to compliance risks, help develop a strategic plan, and ensure its implementation and ongoing adherence to legal and regulatory requirements.
About PDMA Alliance, Inc.
The PDMA Alliance, Inc. (pdmaalliance.org) is the industry voice of PDMA compliance professionals. Its members are dedicated to improving the understanding of the PDMA by the pharmaceutical industry, and to strengthening the efficiency and effectiveness of the sample accountability programs it administers. The Alliance serves as the industry’s focal point for learning, exchanging ideas, and networking on issues related to PDMA compliance. The PDMA Alliance works closely with the U.S. Food and Drug Administration (FDA), and with our members, to continually improve our business and security practices.